Related Experiment Video
Updated: Aug 1, 2025

06:26
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
1.1K
Stimulus-responsive starch-based nanocapsules for targeted delivery and antibacterial applications
Qingye Meng1, Liping Zhou2, Shuangling Zhong3
1College of Chemistry, Jilin University, Changchun 130012, PR China.
International Journal of Biological Macromolecules
|April 29, 2023
Summary
Modified starch nanocapsules loaded with curcumin show potential for biomedical applications. These biocompatible, biodegradable FA-RSNCs@CUR exhibit effective drug release and cellular uptake, with antibacterial properties for food preservation and wound dressing.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery
Background:
- Polysaccharide materials are favored in biomedicine for their safety and biodegradability.
- Starch modification offers a versatile platform for developing novel nanomaterials.
- Curcumin is a potent therapeutic agent with limitations in bioavailability and targeted delivery.
Purpose of the Study:
- To develop novel starch-based nanocapsules loaded with curcumin (FA-RSNCs@CUR).
- To evaluate the drug release kinetics, cellular uptake, biocompatibility, and antibacterial properties of FA-RSNCs@CUR.
- To explore the potential of FA-RSNCs@CUR in food preservation and wound dressing.
Main Methods:
- Starch modification using chloroacetic acid, folic acid (FA), and thioglycolic acid.
- Preparation of curcumin-loaded nanocapsules (FA-RSNCs@CUR) via oxidation method.
- Characterization of particle size, in vitro drug release studies under simulated tumor microenvironment conditions, cellular uptake studies using HeLa cells, cytotoxicity assays, and antibacterial property evaluation.
Main Results:
- FA-RSNCs@CUR were prepared with a stable particle size of approximately 100 nm.
- In vitro drug release studies showed a cumulative curcumin release rate of 85.18% at 12 hours.
- FA-RSNCs@CUR demonstrated rapid internalization by HeLa cells (4 hours) mediated by FA receptors.
- Cytotoxicity assays confirmed good biocompatibility and protection of normal cells.
- FA-RSNCs@CUR exhibited significant in vitro antibacterial properties.
Conclusions:
- FA-RSNCs@CUR are a promising nanocarrier system for curcumin delivery.
- The nanocapsules possess excellent biocompatibility, targeted cellular uptake, and effective drug release.
- FA-RSNCs@CUR show potential for applications in food preservation and wound dressing due to their properties.

